We are monitoring the impact of COVID-19 & Recession alarm on Anti-neoplastic Agents Market Get in touch with us for detailed analysis Know More

✖

Know More

✖

  1. Home
  2. >
  3. Healthcare
  4. >
  5. Anti-neoplastic Agents Market
Share on

Global Anti-neoplastic Agents Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Product Type, End-User and Region – Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 8046
Pages: 175

Anti-neoplastic Agents Market Size (2022 to 2027)

The global anti-neoplastic agents market is estimated to grow at a CAGR of 8.3% from 2022 to 2027. As a result, the market is forecasted to reach USD 185.23 billion by 2027 from USD 124.33 billion in 2022 and USD 114.8 billion in 2021.

Anti-neoplastic agents are drugs that are used as the primary treatment for patients who have cancer. Anti-neoplastic is a variety of medicine to limit or kill tumor cells in the body. It plays a vital role in comprehensive cancer therapy, especially for disseminated tumors and leukemia that cannot be treated with surgery.

MARKET DRIVERS:

Increasing cancer cases incidences, funding from government bodies, technological advancements, and favorable reimbursement policies are majorly propelling the global anti-neoplastic agents market growth.

Anti-neoplastic agents are primarily utilized along with immunotherapy, surgery, hormone therapy, radiotherapy, and targeted therapy for several solid tumors, particularly metastatic. The danger associated with cancer increases with age, and it is now growing common across the globe due to individuals' quickly changing standard of living. Therefore, increasing demand and requirement for anti-neoplastic agents have attracted several major pharmaceutical market players to enter the global market and expand more competent drugs against numerous cancer conditions.

According to the Center for Disease Control and Prevention (CDC), malignant neoplasms account for 15% of deaths worldwide, with 19.3 million new cases of cancer considered to be diagnosed by 2025. As a paradigm, according to the Healthcare Cost and Utilization Project (H-cup), there were 4.7 million hospitalizations associated with cancer in the U.S., and around 6% of the adult population of inpatient hospital cost was caused due to hospitalization of patients with cancer.

Additionally, advanced technologies used up in the anti-neoplastic agents market are one factor that propels the anti-neoplastic agents market growth. Also, private organizations' investments in manufacturing drugs related to cancer and other diseases are accelerating market growth. Growing requirements for the anti-neoplastic pharmaceutical agents that have dragged pharmaceutical industries' attention to get into the market for developing and manufacturing more productive drugs for fighting cancer conditions drive the market growth.

MARKET RESTRAINTS:

The absence of favorable regulatory frameworks is expected to be hampering the growth of the global anti-neoplastic agents market. Moreover, some adverse effects associated with neoplastic agents are further expected to hinder the development of the anti-neoplastic agents market. For instance, strict rules to follow by the top companies in producing drugs are likely to obstruct market growth. Also, the need for FDA approvals for the drug release into the market is restraining the Anti-neoplastic Agents Market growth. Furthermore, a lack of knowledge about cancer in people is impeding the market growth. The diverse nature of cancer and the cost related to its development are high, limiting its growth. Technical Complications related to the existing diagnostic tests are the factors that restrain the anti-neoplastic agents market growth.

Impact of COVID-19 on the global anti-neoplastic agents market:

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries worldwide, with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect the Antineoplastic Interferon Drug market in 2020. COVID-19 can influence the global economy in three ways: directly hitting production and demand, causing supply chain and market disruption, and its financial impact on firms and financial markets. In addition, the outbreak of COVID-19 has affected many aspects, like restrictions on flight travel and all indevents, falling business confidence, growing panic among the population, and uncertainty about the future.

As the different regions' governments have already announced a complete lockdown and temporary closedown of industries, there is a significant loss for the companies, hindering the market's growth rate.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By-Products, End Users, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global anti-neoplastic agents market has been segmented and sub-segmented based on the products, end-users, and region.

Anti-neoplastic Agents Market – By Product:

  • Chemotherapeutic Agents
  • Biological Agents   
  • Personalized Medicine  

Based on the product, the chemotherapeutic agent segment accounts for a significant market share during the forecast period. The chemotherapeutic agents segment is foreseen to lead the market due to the easy availability of drugs. The immunotherapeutic agents segment is expected to proliferate due to increasing biological therapy acceptance and lesser side effects.

Anti-neoplastic Agents Market – By End Users:

  • Hospitals 
  • Clinics        
  • Cancer Rehabilitation Centers            
  • Ambulatory Surgical Centers            

Based on end-users, the hospital segment dominated the anti-neoplastic agents market in 2021. The hospital end-user portion is expected to provide the highest share among end-users. As per the statistics given by The Healthcare Cost and Utilization Project, there were 4.7 Mn hospital admissions related to cancer in the U.S. in 2009. The hospital admission of cancer patients formed about 6% of adult inpatient hospital costs.

Anti-neoplastic Agents Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

The global market was dominated by North America's anti-neoplastic agents market, closely followed by Europe in 2021. Asia Pacific is expected to grow at a high CAGR. The domination of the North American region can be attributed to the standard increase of contagious diseases, and the appearance of highly developed healthcare is one factor that drives this region forward. North America has a vital contribution to the leading market standing. It is estimated to help sustain the market share over the forecast period due to the advanced healthcare infrastructure and facilities, government investment, and the generally followed unhealthy lifestyle of the consumers leading to chronic diseases.

The Europe anti-neoplastic agents market accounted for the second-largest global market share in 2021. The U.K. and Germany contributed majorly to the European market in 2021 with the awareness of anti-neoplastic agents and a growing economy. Cancer Research UK shows that 605 people per 100,000 general populations are diagnosed with cancer. Therefore, countries like the UK and Germany are considered to notice high acceptance of anti-cancer drugs compared with others in this region.

The Asia Pacific anti-neoplastic agents market is expected to be the fastest-growing region in the global market. Japan, India, and China are with the highest shares of the market. Factors such as rising dis, awareness of the advantages of early diagnosis, improving the posable income, and escalating expenditure on the healthcare sector are projected to drive the anti-neoplastic agents market. In this region, countries like Japan and Australia have favorable market development. On the other hand, China and India are considered the most attractive market due to the high incidences of the syndrome and crucial market players' existence.

The Latin American anti-neoplastic agents market is predicted to accelerate at a steady CAGR during the forecast period.

The anti-neoplastic agents market in Middle East and Africa is expected to see a slow and gradual market growth due to a lack of awareness about optimal healthcare and anti-neoplastic agents and a lack of skilled expertise in cancer cures and medical treatments.

KEY MARKET PARTICIPANTS:

Some of the top companies leading the Global Anti-neoplastic Agents Market profiled in this report are Aspen Global Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Johnson & Johnson Pvt. Ltd., Merck & Co., Inc., Pfizer Inc., Hoffmann-La Roche Ltd., Amgen Inc., Bristol-Myers Squibb Company, Baxter Healthcare Corporation, Boehringer Ingelheim GmbH, Accord Healthcare, Inc., Genentech, Inc., Lundbeck LLC, and AbbVie Inc.

Genentech, one of the leading companies, has been approved by the FDA to accept atezolizumab, which is the treatment used by the patient suffering from metastatic non-small lung cancer for those whose tumor is high with PD-L1 expression.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Chemotherapeutic agent 

                                5.1.3 Biological agents   

                                5.1.4 Personalied medicine         

                                5.1.5  Y-o-Y Growth Analysis, By Product              

                                5.1.6  Market Attractiveness Analysis, By Product            

                                5.1.7  Market Share Analysis, By Product              

                5.2 End user                      

                                5.2.1 Introduction           

                                5.2.2 Hospitals  

                                5.2.3 Clinics        

                                5.2.4 Cancer rehabilitaion centers            

                                5.2.5 Ambulatory surgical centers            

                                5.2.6 Y-o-Y Growth Analysis, By end user             

                                5.2.7 Market Attractiveness Analysis, By end user           

                                5.2.8 Market Share Analysis, By end user             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By end user

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By end user

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By end user

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Hoffmann-La Roche Ltd                        

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Amgen Inc.                 

                8.3 Bristol-Myers Squibb Company                         

                8.4 Baxter Healthcare Corporation                          

                8.5 Boehringer Ingelheim GmbH                              

                8.6 Aspen Global Inc.                     

                8.7 Bayer AG                     

                8.8 Teva pharmaceutical Industries Ltd.                

                8.9 Johnson & Johnson Pvt. Ltd.                               

                8.10 Accord Healthcare, Inc.                       

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Global Anti-neoplastic agents Market, By Region, From 2022 - 2027 (USD Million)
  2. Global Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  3. Global Chemotherapeutic agents Market, By Region, From 2022 - 2027 (USD Million)
  4. Global Biological agents Market, By Region, From 2022 - 2027 (USD Million)
  5. Global Personalised medicine Market, By Region, From 2022 - 2027 (USD Million)
  6. Global Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  7. Global Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  8. Global Clinics Market, By Region, From 2022 - 2027 (USD Million)
  9. Global Cancer rehabilitation centers Market, By Region, From 2022 - 2027 (USD Million)
  10. Global Ambulatory surgical centers Market, By Region, From 2022 - 2027 (USD Million)
  11. North America Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  12. North America Chemotherapeutic agents Market, By Region, From 2022 - 2027 (USD Million)
  13. North America Biological agents Market, By Region, From 2022 - 2027 (USD Million)
  14. North America Personalised medicine Market, By Region, From 2022 - 2027 (USD Million)
  15. North America Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  16. North America Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  17. North America Clinics Market, By Region, From 2022 - 2027 (USD Million)
  18. North America Cancer rehabilitation centers Market, By Region, From 2022 - 2027 (USD Million)
  19. North America Ambulatory surgical centers Market, By Region, From 2022 - 2027 (USD Million)
  20. United States Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  21. United States Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  22. Canada Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  23. Canada Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  24. Europe Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  25. Europe Chemotherapeutic agents Market, By Region, From 2022 - 2027 (USD Million)
  26. Europe Biological agents Market, By Region, From 2022 - 2027 (USD Million)
  27. Europe Personalised medicine Market, By Region, From 2022 - 2027 (USD Million)
  28. Europe Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  29. Europe Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  30. Europe Clinics Market, By Region, From 2022 - 2027 (USD Million)
  31. Europe Cancer rehabilitation centers Market, By Region, From 2022 - 2027 (USD Million)
  32. Europe Ambulatory surgical centers Market, By Region, From 2022 - 2027 (USD Million)
  33. U.K. Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  34. U.K. Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  35. Germany Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  36. Germany Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  37. France Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  38. France Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  39. Italy Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  40. Italy Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  41. Spain Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  42. Spain Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  43. Asia Pacific Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  44. Asia Pacific Chemotherapeutic agents Market, By Region, From 2022 - 2027 (USD Million)
  45. Asia Pacific Biological agents Market, By Region, From 2022 - 2027 (USD Million)
  46. Asia Pacific Personalised medicine Market, By Region, From 2022 - 2027 (USD Million)
  47. Asia Pacific Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  48. Asia Pacific Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  49. Asia Pacific Clinics Market, By Region, From 2022 - 2027 (USD Million)
  50. Asia Pacific Cancer rehabilitation centers Market, By Region, From 2022 - 2027 (USD Million)
  51. Asia Pacific Ambulatory surgical centers Market, By Region, From 2022 - 2027 (USD Million)
  52. Japan Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  53. Japan Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  54. China Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  55. China Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  56. India Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  57. India Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  58. Australia Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  59. Australia Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  60. South Korea Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  61. South Korea Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  62. Latin America Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  63. Latin America Chemotherapeutic agents Market, By Region, From 2022 - 2027 (USD Million)
  64. Latin America Biological agents Market, By Region, From 2022 - 2027 (USD Million)
  65. Latin America Personalised medicine Market, By Region, From 2022 - 2027 (USD Million)
  66. Latin America Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  67. Latin America Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  68. Latin America Clinics Market, By Region, From 2022 - 2027 (USD Million)
  69. Latin America Cancer rehabilitation centers Market, By Region, From 2022 - 2027 (USD Million)
  70. Latin America Ambulatory surgical centers Market, By Region, From 2022 - 2027 (USD Million)
  71. Brazil Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  72. Brazil Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  73. Argentina Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  74. Argentina Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  75. Mexico Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  76. Mexico Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  77. Rest of Latin America Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  78. Rest of Latin America Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  79. Middle East and Africa Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  80. Middle East and Africa Chemotherapeutic agents Market, By Region, From 2022 - 2027 (USD Million)
  81. Middle East and Africa Biological agents Market, By Region, From 2022 - 2027 (USD Million)
  82. Middle East and Africa Personalised medicine Market, By Region, From 2022 - 2027 (USD Million)
  83. Middle East and Africa Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  84. Middle East and Africa Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  85. Middle East and Africa Clinics Market, By Region, From 2022 - 2027 (USD Million)
  86. Middle East and Africa Cancer rehabilitation centers Market, By Region, From 2022 - 2027 (USD Million)
  87. Middle East and Africa Ambulatory surgical centers Market, By Region, From 2022 - 2027 (USD Million)
  88. Middle East Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  89. Middle East Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  90. Africa Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  91. Africa Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  92. North America Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  93. North America Chemotherapeutic agents Market, By Region, From 2022 - 2027 (USD Million)
  94. North America Biological agents Market, By Region, From 2022 - 2027 (USD Million)
  95. North America Personalised medicine Market, By Region, From 2022 - 2027 (USD Million)
  96. North America Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  97. North America Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  98. North America Clinics Market, By Region, From 2022 - 2027 (USD Million)
  99. North America Cancer rehabilitation centers Market, By Region, From 2022 - 2027 (USD Million)
  100. North America Ambulatory surgical centers Market, By Region, From 2022 - 2027 (USD Million)
  101. United States Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  102. United States Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  103. Canada Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  104. Canada Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  105. Europe Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  106. Europe Chemotherapeutic agents Market, By Region, From 2022 - 2027 (USD Million)
  107. Europe Biological agents Market, By Region, From 2022 - 2027 (USD Million)
  108. Europe Personalised medicine Market, By Region, From 2022 - 2027 (USD Million)
  109. Europe Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  110. Europe Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  111. Europe Clinics Market, By Region, From 2022 - 2027 (USD Million)
  112. Europe Cancer rehabilitation centers Market, By Region, From 2022 - 2027 (USD Million)
  113. Europe Ambulatory surgical centers Market, By Region, From 2022 - 2027 (USD Million)
  114. U.K. Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  115. U.K. Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  116. Germany Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  117. Germany Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  118. France Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  119. France Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  120. Italy Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  121. Italy Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  122. Spain Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  123. Spain Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  124. Asia Pacific Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  125. Asia Pacific Chemotherapeutic agents Market, By Region, From 2022 - 2027 (USD Million)
  126. Asia Pacific Biological agents Market, By Region, From 2022 - 2027 (USD Million)
  127. Asia Pacific Personalised medicine Market, By Region, From 2022 - 2027 (USD Million)
  128. Asia Pacific Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  129. Asia Pacific Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  130. Asia Pacific Clinics Market, By Region, From 2022 - 2027 (USD Million)
  131. Asia Pacific Cancer rehabilitation centers Market, By Region, From 2022 - 2027 (USD Million)
  132. Asia Pacific Ambulatory surgical centers Market, By Region, From 2022 - 2027 (USD Million)
  133. Japan Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  134. Japan Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  135. China Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  136. China Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  137. India Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  138. India Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  139. Australia Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  140. Australia Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  141. South Korea Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  142. South Korea Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  143. Latin America Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  144. Latin America Chemotherapeutic agents Market, By Region, From 2022 - 2027 (USD Million)
  145. Latin America Biological agents Market, By Region, From 2022 - 2027 (USD Million)
  146. Latin America Personalised medicine Market, By Region, From 2022 - 2027 (USD Million)
  147. Latin America Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  148. Latin America Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  149. Latin America Clinics Market, By Region, From 2022 - 2027 (USD Million)
  150. Latin America Cancer rehabilitation centers Market, By Region, From 2022 - 2027 (USD Million)
  151. Latin America Ambulatory surgical centers Market, By Region, From 2022 - 2027 (USD Million)
  152. Brazil Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  153. Brazil Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  154. Argentina Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  155. Argentina Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  156. Mexico Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  157. Mexico Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  158. Rest of Latin America Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  159. Rest of Latin America Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  160. Middle East and Africa Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  161. Middle East and Africa Chemotherapeutic agents Market, By Region, From 2022 - 2027 (USD Million)
  162. Middle East and Africa Biological agents Market, By Region, From 2022 - 2027 (USD Million)
  163. Middle East and Africa Personalised medicine Market, By Region, From 2022 - 2027 (USD Million)
  164. Middle East and Africa Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  165. Middle East and Africa Hospitals Market, By Region, From 2022 - 2027 (USD Million)
  166. Middle East and Africa Clinics Market, By Region, From 2022 - 2027 (USD Million)
  167. Middle East and Africa Cancer rehabilitation centers Market, By Region, From 2022 - 2027 (USD Million)
  168. Middle East and Africa Ambulatory surgical centers Market, By Region, From 2022 - 2027 (USD Million)
  169. Middle East Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  170. Middle East Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
  171. Africa Anti-neoplastic agents Market, By Product, From 2022 - 2027 (USD Million)
  172. Africa Anti-neoplastic agents Market, By End user, From 2022 - 2027 (USD Million)
↻

Please wait. . . . Your request is being processed

FAQ's

How big is the anti-neoplastic agents market?

The global anti-neoplastic agents market size was worth USD 114.8 billion in 2021.

What is the growth rate of the global anti-neoplastic agents market?

During the forecast period, the global anti-neoplastic agents market is expected to grow at a CAGR of 8.3%

Which region led the anti-neoplastic agents market in 2021?

Geographically, the North American region accounted major share of the global market in 2021.

Who are the key players in the anti-neoplastic agents market?

Aspen Global Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Johnson & Johnson Pvt. Ltd., Merck & Co., Inc., Pfizer Inc., Hoffmann-La Roche Ltd., Amgen Inc., Bristol-Myers Squibb Company, Baxter Healthcare Corporation, Boehringer Ingelheim GmbH, Accord Healthcare, Inc., Genentech, Inc., Lundbeck LLC, and AbbVie Inc. are some of the notable companies in the anti-neoplastic agents market.

Related Reports

Precision Medicine Market

Jan 2022

Download Sample
PURCHASE OPTIONS
pdf
$

4255

pdf excel
$

5060

pdf excel powerbi
$

7360

excel
$

2500

What You Get :

  • ✔ PDF Report Format.
  • ✔ Can be accessible by 1 single user.
  • ✔ 6 Months of Free Analyst Support.
  • ✔ PDF and Excel Datasheet Formats.
  • ✔ Can be accessible upto 2 to 5 users.
  • ✔ 1 Year of Free Analyst Support.
  • ✔ PDF, Excel and Power BI Dashboard.
  • ✔ Can be accessible by unlimited users.
  • ✔ 1 Year of Free Analyst Support.
  • ✔ Excel Datasheet Format.
  • ✔ Customized access as per user request.
  • ✔ Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 4255

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Research Areas

Reports By Region
Reports By Industry
Click for Request Sample